28.4, 28.3, 28.0, 21.7, 21.6, and 21.6; IR (film) 2979, 1732, 1706,
and 1393 cm-1; CIMS m/z (rel intensity) 370 (43%, MH+), 314
(100), 282 (36), and 258 (36); C19H32NO6 requires M, 370.2230,
found MH+, 370.2238.
(2RS)-N,N-Diisop r op yl 2-Ca r b om et h oxy-2,5-d ih yd r o-
fu r a n -2-ca r boxa m id e, 20. By method B, furan 17 (195 mg, 1.0
mmol) and methyl chloroformate (270 µL, 3.5 mmol) gave the
title compound as a solid (213 mg, 84%) after chromatography
[(i) light petrol; (ii) light petrol-20% EtOAc]; 1H NMR (200 MHz,
CDCl3) δ 6.09 (dt, J 6.0 and 1.2 Hz, 1 H), 6.04 (dt, J 6.0 and 2.0
Hz, 1 H), 4.87 (ddd, J 13.2, 2.4, and 1.6 Hz, 1 H), 4.78 (ddd, J
13.2, 2.4, and 2.0 Hz, 1 H), 4.23 (sp, J 6.8 Hz, 1 H), 3.76 (s, 3 H),
3.33 (sp, J 6.8 Hz, 1 H), 1.39 (d, J 6.8 Hz, 3 H), 1.36 (d, J 6.8
(2RS)-Isop r op yl 1-(ter t-Bu t yloxyca r b on yl)-2-b en zoyl-
2,5-d ih yd r op yr r ole-2-ca r boxyla te, 10. By method B, pyrrole
3 (253 mg, 1.0 mmol) and benzoyl chloride (350 µL, 3.0 mmol)
gave the title compound as an oil (240 mg, 67%) after chroma-
1
tography [(i) light petrol; (ii) light petrol-20% Et2O]; H NMR
Hz, 3 H), 1.16 (d, J 6.8 Hz, 3 H), and 1.02 (d, J 6.8 Hz, 3 H); 13
C
(400 MHz, CDCl3) δ 7.83-7.76 (m, 4 H), 7.63-7.43 (m, 2 H),
7.41-7.32 (m, 4 H), 6.17 (dt, J 6.4 and 2.0 Hz, 2 H), 6.10 (dt, J
6.0 and 2.4 Hz, 2 H), 5.13 (sp, J 6.4 Hz, 1 H), 5.12 (sp, J 6.0 Hz,
1 H), 4.50 (dt, J 16.4 and 2.0 Hz, 1 H), 4.39 (dt, J 16.4 and 2.0
Hz, 1 H), 4.35-4.31 (m, 2 H), 1.34 (d, J 6.0 Hz, 3 H), 1.32 (s, 9
H), 1.30 (d, J 6.0 Hz, 3 H), 1.28 (d, J 6.0 Hz, 3 H), 1.24 (d, J 6.0
Hz, 3 H), 1.18 (s, 9 H); 13C NMR (101 MHz, CDCl3) δ 192.5,
167.4, 153.0, 135.7, 132.7, 131.9, 130.1, 129.9, 129.3, 129.3, 128.4,
128.3, 128.3, 127.9, 82.5, 81.4, 80.4, 69.6, 53.9, 53.6, 28.1, 27.6,
21.7, and 21.6; IR (film) 2981, 1745, 1706, and 1392 cm-1; CIMS
m/z (rel intensity) 360 (4%, MH+), 304 (23), 244 (18), 171 (21),
154 (100), and 153 (24); C20H26NO5 requires M, 360.1811, found
MH+, 360.1813. Anal. Calcd for C20H25NO5: C, 66.83; H, 7.01;
N, 3.90. Found: C, 67.01; H, 7.01; N, 3.98.
NMR (50 MHz, CDCl3) δ 171.0, 166.7, 129.1, 127.6, 95.2, 77.3,
52.7, 48.6, 46.4, 20.7, 20.2, 20.0, and 19.6; IR (film) 2968, 1752,
1735, 1649, and 1443 cm-1; CIMS m/z (rel intensity) 256 (45%,
MH+), 196 (100), and 130 (46); C13H22NO4 requires M, 256.1549,
found MH+, 256.1542; mp 90-91 °C.
(1RS)-1-[(ter t-Bu tyl)m eth yl Ca r boxyla te]-cycloh exa -2,5-
d ien yl-1-ca r bon itr ile, 22. By method B, benzonitrile 21 (102
µL, 1.0 mmol) and tert-butyl bromoacetate (443 µL, 3.0 mmol)
gave the title compound as an oil (175 mg, 80%) after chroma-
tography [(i) light petrol; (ii) light petrol-10% EtOAc]; 1H NMR
(300 MHz, CDCl3) δ 6.02 (dt, J 10.2 and 3.4 Hz, 2 H), 5.83 (dt,
J 10.2 and 1.9 Hz, 2 H), 2.78-2.70 (m, 2 H), 2.65 (s, 2 H), and
1.51 (s, 9 H); 13C NMR (75 MHz, CDCl3) δ 167.4, 127.6, 123.5,
120.5, 81.9, 46.0, 34.3, 27.9, and 25.5; IR (film) 2235, 1732, and
1154 cm-1; CIMS m/z (rel intensity) 237 (100%, MNH4+), 220
(38, MH+), 181 (28), and 164 (16); C13H18NO2 requires M,
220.1338, found MH+, 220.1333.
(2RS)-1-(ter t-Bu tyloxyca r bon yl)-2-d im eth oxyca r bon yl-
2,5-d ih yd r op yr r ole, 12. By method B, pyrrole 11 (225 mg, 1.0
mmol) and methyl chloroformate (193 µL, 2.5 mmol) gave the
title compound as a solid (173 mg, 61%) after chromatography
[(i) light petrol; (ii) light petrol-20% Et2O]; 1H NMR (300 MHz,
CDCl3) δ 6.12 (dt, J 6.0 and 2.1 Hz, 1 H), 6.08 (dt, J 6.2 and 2.0
Hz, 1 H), 5.87 (dt, J 6.1 and 2.1 Hz, 1 H), 5.84 (dt, J 6.2 and 2.2
Hz, 1 H), 4.35 (t, J 2.1 Hz, 2 H), 4.30 (t, J 1.9 Hz, 2 H), 3.82 (s,
6 H), 3.81 (s, 6 H), 1.52 (s, 9 H), and 1.45 (s, 9 H); 13C NMR (75
MHz, CDCl3) δ 167.7, 130.3, 130.2, 126.6, 126.5, 80.9, 54.2, 54.1,
(1RS)-1-Meth oxyca r bon yl-cycloh exa -2,5-d ien yl-1-ca r bo-
n itr ile, 23. By method B, benzonitrile 21 (102 µL, 1.0 mmol)
and methyl chloroformate (386 µL, 5.0 mmol) gave the title
compound as an oil (94 mg, 58%) after chromatography [(i) light
1
petrol; (ii) light petrol-10% Et2O]; H NMR (200 MHz, CDCl3)
52.9, 52.8, 28.2, and 28.0; IR (film) 1756, 1710, and 1393 cm-1
;
δ 6.20-6.09 (m, 2 H), 5.88-5.77 (m, 2 H), 3.85 (s, 3 H), and 2.82-
CIMS m/z (rel intensity) 286 (7%, MH+), 247 (33), 230 (100),
186 (77), and 126 (46); C13H19NO6Na requires M, 308.1110, found
MNa+, 308.1106; mp 71-73 °C.
2.74 (m, 2 H); 13C NMR (50 MHz, CDCl3) δ 167.2, 129.5, 119.4,
117.5, 54.1, 43.6, and 25.4; IR (film) 2242, 1749, and 1254 cm-1
;
CIMS m/z (rel intensity) 181 (100%, MNH4+) and 118 (16);
C9H13N2O2 requires M, 181.0977, found MNH4+, 181.0974.
(2RS)-N,N-Diisop r op yl 2-Ben zyl-2,5-d ih yd r ofu r a n -2-ca r -
boxa m id e, 18. By method B, furan 17 (195 mg, 1.0 mmol) and
benzyl bromide (415 µL, 3.5 mmol) gave the title compound as
a solid (241 mg, 84%) after chromatography [(i) light petrol; (ii)
(1RS)-1-(3′-P h en yl-p r op -2′-en yl)-cycloh exa -2,5-d ien yl-1-
ca r b on it r ile, 24. By method B, benzonitrile 21 (102 µL, 1.0
mmol) and cinnamyl bromide (493 mg, 2.5 mmol) gave the title
compound as an oil (147 mg, 67%) after chromatography [(i) light
petrol; (ii) light petrol-5% Et2O]; 1H NMR (400 MHz, CDCl3) δ
7.40-7.30 (m, 4 H), 7.28-7.22 (m, 1 H), 6.51 (br d, J 16.0 Hz, 1
H), 6.20 (dt, J 15.2 and 8.0 Hz, 1 H), 6.02-5.95 (m, 2 H), 5.74-
5.68 (m, 2 H), 2.75 (dtt, J 23.2, 3.2, and 2.0 Hz, 1 H), 2.65 (dtt,
J 23.2, 3.2, and 2.0 Hz, 1 H) and 2.64 (dd, J 7.6 and 1.6 Hz, 2
H); 13C NMR (101 MHz, CDCl3) δ 136.8, 135.1, 128.6, 127.7,
127.5, 126.3, 124.1, 122.4, 121.3, 44.6, 37.0, and 25.7; IR (film)
3030, 2231, 1598, and 1494 cm-1; CIMS m/z (rel intensity) 239
(100%, MNH4+), 117 (49), and 91 (8); C16H19N2 requires M,
239.1548, found MNH4+, 239.1544.
1
light petrol-20% EtOAc]; H NMR (200 MHz, CDCl3) δ 7.31-
7.15 (m, 5 H), 6.09 (dt, J 6.0 and 2.6 Hz, 1 H), 5.74 (dt, J 6.0
and 1.6 Hz, 1 H), 4.92 (sp, J 6.6 Hz, 1 H), 4.57 (ddd, J 12.8, 2.6,
and 1.8 Hz, 1 H), 4.33 (ddd, J 12.8, 2.6, and 1.8 Hz, 1 H), 3.35
(sp, J 6.6 Hz, 1 H), 3.19 (d, J 14.0 Hz, 1 H), 3.03 (d, J 13.6 Hz,
1 H), 1.42 (d, J 6.6 Hz, 3 H), 1.37 (d, J 6.6 Hz, 3 H), 1.14 (d, J
6.6 Hz, 3 H) and 1.05 (d, J 6.6 Hz, 3 H); 13C NMR (101 MHz,
CDCl3) δ 171.9, 136.3, 132.0, 130.6, 127.8, 126.4, 125.7, 96.7,
77.2, 48.1, 46.5, 44.5, 20.9, 20.6, 20.5, and 20.3; IR (film) 2966,
1620, and 1440 cm-1; CIMS m/z (rel intensity) 288 (100%, MH+),
196 (72), and 159 (79); C18H26NO2 requires M, 288.1964, found
MH+, 288.1976; mp 64-65 °C.
(2RS)-N,N-Diisop r op yl 2-Meth yl-2,5-d ih yd r ofu r a n -2-ca r -
boxa m id e, 19. By method B, furan 17 (195 mg, 1.0 mmol) and
methyl iodide (218 µL, 3.5 mmol) gave the title compound as an
oil (135 mg, 64%) after chromatography [(i) light petrol; (ii) light
petrol-20% EtOAc]; 1H NMR (200 MHz, CDCl3) δ 6.13 (dt, J
6.0 and 2.4 Hz, 1 H), 5.87 (dt, J 6.0 and 1.6 Hz, 1 H), 4.81 (sp,
J 6.4 Hz, 1 H), 4.69 (ddd, J 12.8, 2.0 and 1.6 Hz, 1 H), 4.64 (ddd,
J 12.8, 2.4 and 1.6 Hz, 1 H), 3.35 (sp, J 6.4 Hz, 1 H), 1.50 (s, 3
H), 1.40 (d, J 6.8 Hz, 3 H), 1.37 (d, J 6.8 Hz, 3 H), 1.19 (d, J 6.8
Hz, 3 H), and 1.16 (d, J 6.8 Hz, 3 H); 13C NMR (101 MHz, CDCl3)
δ 172.7, 133.6, 124.6, 92.9, 75.6, 48.1, 46.3, 25.4, 20.6, 20.5, 20.5,
and 20.5; IR (film) 2968, 1630, and 1438 cm-1; CIMS m/z (rel
intensity) 212 (100%, MH+), 130 (31), and 83 (12); C12H22NO2
requires M, 212.1651, found MH+, 212.1643.
Ack n ow led gm en t. We thank the EPSRC (Grant
GR/N19946) for supporting this project and Pfizer for
unrestricted financial support. Part of this work was
carried out at the University of Manchester.
Su p p or tin g In for m a tion Ava ila ble: Preparation of DBB;
1
data for compounds 5, 6, syn/anti-8, 14, 16, 26; copies of H
NMR spectra for compounds 6, anti-8, 9, 18, 19, 20, 22, 23,
24. This material is available free of charge via the Internet
at http://pubs.acs.org.
J O0257593
5018 J . Org. Chem., Vol. 67, No. 14, 2002